NYSE - Arena Pharmaceuticals, Inc.

График котировок Arena Pharmaceuticals, Inc.


Добавить в список сравнения Добавить в список сравнения
Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

P/S 12.537
P/BV 3.6
EV/EBITDA -6.99
EBITDA -0.4228
Цена ао 66.29

Все параметры ⇨

Оценка

Недооценка

Название Значение Оценка
P/S 12.537 1
P/BV 3.6 2
P/E 0
EV/EBITDA -6.99 10

Эффективность

Название Значение Оценка
ROA, % -22.55 1
ROE, % -37.62 1

Дивиденды

Название Значение Оценка
Div yield, % 0
DSI 0 0

Долг

Название Значение Оценка
Долг/EBITDA 10

Импульс роста

Название Значение Оценка
Рост прибыли, % 0 0
Рост цены акции, % 0 0
Рост дивидендов, % 0 0

Основные владельцы

Институционалы Объем Доля, %
FIL Fund Management Limited 501505116 6.91
Grandeur Peak Global Advisors, LLC 402488200 5.55
Fidelity Investment Services Ltd 173948600 2.4
Coupland Cardiff Asset Management LLP 100229400 1.38
Matthews International Cap Mgmt LLc 53015500 0.73
McInroy & Wood Ltd 52000000 0.72
McInroy & Wood Ltd 52000000 0.72
Mondrian Investment Partners Ltd 47101000 0.65
Dimensional Fund Advisors 37990200 0.52
Dimensional Fund Advisors LP 23243389 0.32
Allianz Global Investors Asia Pacific Limited 23150900 0.32
Danske Bank Asset Management 18482893 0.25
J O Hambro Capital Management Limited 14728576 0.2
Aberdeen Standard Investments (Asia) Limited 14519600 0.2
JOM Rahastoyhtiö Oy/ Fund Management Ltd 9000000 0.12
Degroof Petercam Asset Services S.A. 6493524 0.09
Mitsubishi UFJ Kokusai Asst Mgmt Co.,Ltd 2528500 0.03
Edmond de Rothschild Asset Management (Lux) 2337197 0.03
John Hancock Investment Management LLC 1880900 0.03
Dimensional Fund Advisors Ltd 1646000 0.02
FIL Gestion 1630530 0.02
PT Ashmore Asset Management Indonesia 1303600 0.02
Maybank Asset Management Singapore Pte. Ltd 744800 0.01
Fidelity (FIL Inv Mgmt (Lux) S.A.) 3927 0
Fidelity (FIL Fund Management Limited) 0 0

Содержится в ETF

ETF Доля, % Доходность за год, % Дивиденды, %
ALPS Medical Breakthroughs ETF 2.9 34.59 0.50
AdvisorShares Pure Cannabis ETF 2.57 174.17 0.99
Indxx MicroSectors Cannabis ETN 2.36 84.66 0.70
Cambria Cannabis ETF 2.87 81.04 2.85
Indxx MicroSectors Cannabis 2X Leveraged ETN 2.36 194.65 0.95

Похожие компании

Описание Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, a Phase IIb\u002FIII clinical trial for Crohn's disease, and a Phase IIb clinical trial for atopic dermatitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; and APD418 that is in Phase I clinical trial for acute heart failure. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; and Eisai Co., Ltd. and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.